Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P74
Within normal range
vs 2Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q4 2025 | 13.54% |
| Q3 2025 | 14.29% |
| Q2 2025 | -117.15% |
| Q1 2025 | 454.77% |
| Q4 2024 | -32.96% |
| Q3 2024 | 0.00% |
| Q2 2024 | 100.00% |
| Q1 2024 | -51.90% |
| Q4 2023 | 24.13% |
| Q3 2023 | -28.03% |
| Q2 2023 | 28.27% |
| Q1 2023 | 8.70% |
| Q4 2022 | -33.22% |
| Q3 2022 | 9.81% |
| Q2 2022 | 36.17% |
| Q1 2022 | -17.34% |
| Q4 2021 | 12.84% |
| Q3 2021 | -7.53% |
| Q2 2021 | -6.20% |
| Q1 2021 | -54.22% |
| Q4 2020 | -38.19% |
| Q3 2020 | 15.44% |
| Q2 2020 | -20.08% |
| Q1 2020 | -50.66% |
| Q4 2019 | -41.86% |
| Q3 2019 | -5.88% |
| Q2 2019 | 27.38% |
| Q1 2019 | -188.32% |
| Q4 2018 | -28.03% |
| Q3 2018 | 12.70% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |